Check-Cap Ltd.
CHEK | NASDAQ
$1.86
+$0.03 (+1.64%)
At close: May 21, 2026, 09:30 AM ET
Company Profile
Check-Cap Ltd. is an Israeli medical diagnostics company currently in the clinical development phase. It is dedicated to advancing a novel capsule-based screening method that employs ultra-low-dose X-rays. This technology is designed to thoroughly examine the internal surface of the colon, aiming to identify precancerous polyps and other structural irregularities. The company's primary offering, the C-Scan system, is composed of three integral parts: the C-Scan Cap, an ingestible X-ray scanning capsule for detecting suspected polyps; the C-Scan Track, a disposable unit that adheres to the patient's back via biocompatible adhesive patches; and the C-Scan View software. This client/server application enables the download of procedural data from the C-Scan Track, performs detailed analysis, and generates comprehensive reports. Check-Cap Ltd. was founded in 2004 and operates from its headquarters in Isfiya, Israel.
Key Executives
| Name | Position |
|---|---|
| David Lontini | Interim Chief Executive Officer & Chairman of the Board |
| Alan Lewis | Chief Financial Officer |
| Noa Reshef | Head of Operations |
Check-Cap Ltd.
| Country | Israel |
| IPO Date | Mar 4, 2015 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 85 |
| CEO | David Lontini |
Stock Details
| Ticker Symbol | CHEK |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001610590 |
| CUSIP Number | M2361E203 |
| ISIN Number | IL0011336851 |
| SIC Code | 3844 |
Add to Watchlist
Select watchlists to add or remove CHEK